loadpatents
name:-0.036043882369995
name:-0.028705835342407
name:-0.0021967887878418
Cameron; Kimberly O. Patent Filings

Cameron; Kimberly O.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cameron; Kimberly O..The latest application filed is for "anti-proliferative agents for treating pah".

Company Profile
1.26.26
  • Cameron; Kimberly O. - Cambridge MA
  • Cameron; Kimberly O. - East Lyme CT US
  • CAMERON, KIMBERLY O - EAST LYME CT
  • Cameron; Kimberly O. - Groton CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-proliferative agents for treating PAH
Grant 11,203,594 - Bhattacharya , et al. December 21, 2		2021-12-21
Anti-proliferative Agents For Treating Pah
App 20200331909 - Bhattacharya; Samit Kumar ;   et al.		2020-10-22
2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5]nonane Derivatives
App 20140080756 - Bhattacharya; Samit K. ;   et al.		2014-03-20
2,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives
Grant 8,609,680 - Bhattacharya , et al. December 17, 2		2013-12-17
2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5] Nonane Derivatives
App 20110230461 - Bhattacharya; Samit K. ;   et al.		2011-09-22
Estrogen Agonists/Antagonists For Preventing Breast Cancer
App 20100317712 - Cameron; Kimberly O. ;   et al.		2010-12-16
Prostaglandin agonists
Grant 7,442,702 - Cameron , et al. October 28, 2		2008-10-28
Methods of treatment with selective EP4 receptor agonists
Grant 7,414,071 - Cameron , et al. August 19, 2		2008-08-19
Tetraazabenzo[e]azulene derivatives and analogs thereof
Grant 7,358,242 - Elliott , et al. April 15, 2		2008-04-15
Tetraazabenzo[e]azulene Derivatives And Analogs Thereof
App 20070265193 - Elliott; Richard L. ;   et al.		2007-11-15
Tetraazabenzo[e]azulene derivatives and analogs thereof
Grant 7,265,104 - Elliott , et al. September 4, 2		2007-09-04
5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating osteoporosis
Grant RE39,558 - Cameron , et al. April 10, 2		2007-04-10
EP4 receptor selective agonist in the treatment of osteoporosis
Grant 7,192,979 - Cameron , et al. March 20, 2		2007-03-20
Acyclic amide and sulfonamide ligands for the estrogen receptor
Grant 7,053,212 - Cameron , et al. May 30, 2		2006-05-30
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
Grant 6,998,423 - Cameron , et al. February 14, 2		2006-02-14
Tetraazabenzo[e]azulene derivatives and analogs thereof
App 20050267100 - Elliott, Richard L. ;   et al.		2005-12-01
Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-ac etic acid
Grant 6,852,863 - Cameron , et al. February 8, 2		2005-02-08
EP4 receptor selective agonists in the treatment of osteoporosis
App 20040259921 - Cameron, Kimberly O. ;   et al.		2004-12-23
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
App 20040192685 - Cameron, Kimberly O. ;   et al.		2004-09-30
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
App 20040176461 - Cameron, Kimberly O. ;   et al.		2004-09-09
Benzothiophenes and related compounds as estrogen agonists
Grant 6,756,388 - Cameron , et al. June 29, 2		2004-06-29
Acyclic amide and sulfonamide ligands for the estrogen receptor
App 20040110767 - Cameron, Kimberly O. ;   et al.		2004-06-10
EP4 receptor selective agonists in the treatment of osteoporosis
Grant 6,747,054 - Cameron , et al. June 8, 2		2004-06-08
EP4 receptor selective agonists in the treatment of osteoporosis
Grant 6,737,437 - Cameron , et al. May 18, 2		2004-05-18
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
App 20030220494 - Cameron, Kimberly O. ;   et al.		2003-11-27
Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-meth- yl}-phenoxy)-acetic acid
App 20030216445 - Cameron, Kimberly O. ;   et al.		2003-11-20
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
Grant 6,649,657 - Cameron , et al. November 18, 2		2003-11-18
Methods of treatment with selective EP4 receptor agonists
App 20030207925 - Cameron, Kimberly O. ;   et al.		2003-11-06
EP4 receptor selective agonists in the treatment of osteoporosis
Grant 6,642,266 - Cameron , et al. November 4, 2		2003-11-04
Use of selective EP4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
App 20030176479 - Cameron, Kimberly O. ;   et al.		2003-09-18
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
Grant 6,608,203 - Cameron , et al. August 19, 2		2003-08-19
EP4 receptor selective agonists in the treatment of osteoporosis
App 20030149086 - Cameron, Kimberly O. ;   et al.		2003-08-07
Prostaglandin agonists
App 20030078261 - Cameron, Kimberly O. ;   et al.		2003-04-24
Prostaglandin agonists
Grant 6,531,485 - Cameron , et al. March 11, 2		2003-03-11
Prostaglandin Agonists
App 20030008895 - CAMERON, KIMBERLY O ;   et al.		2003-01-09
Prostaglandin agonists and their use to treat bone disorders
Grant 6,498,172 - Cameron , et al. December 24, 2		2002-12-24
Osteoporosis compounds
App 20020165255 - Cameron, Kimberly O. ;   et al.		2002-11-07
Estrogen agonists/antagonists for preventing breast cancer
App 20020132816 - Cameron, Kimberly O. ;   et al.		2002-09-19
Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
Grant 6,426,359 - Cameron , et al. July 30, 2		2002-07-30
EP4 receptor selective agonists in the treatment of osteoporosis
App 20020065308 - Cameron, Kimberly O. ;   et al.		2002-05-30
EP4 receptor selective agonists in the treatment of osteoporosis
App 20020040149 - Cameron, Kimberly O. ;   et al.		2002-04-04
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
App 20020016368 - Cameron, Kimberly O. ;   et al.		2002-02-07
Treatment of osteoporsis with EP2/EP4 receptor selective agonists
App 20010056060 - Cameron, Kimberly O. ;   et al.		2001-12-27
EP4 receptor selective agonists in the treatment of osteoporosis
App 20010047105 - Cameron, Kimberly O. ;   et al.		2001-11-29
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
App 20010039285 - Cameron, Kimberly O. ;   et al.		2001-11-08
Estrogen agonists/antagonists for preventing breast cancer
App 20010025051 - Cameron, Kimberly O. ;   et al.		2001-09-27
Estrogen agonists/antagonists
Grant 6,204,286 - Cameron , et al. March 20, 2		2001-03-20
Estrogen agonists/antagonists
Grant 6,153,622 - Cameron , et al. November 28, 2		2000-11-28
Osteoporosis compounds
Grant 6,124,314 - Cameron , et al. September 26, 2		2000-09-26
Bone deposition by certain prostaglandin agonists
Grant 5,703,108 - Cameron , et al. December 30, 1		1997-12-30
5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
Grant 5,552,412 - Cameron , et al. September 3, 1		1996-09-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed